Literature DB >> 22051568

A mathematical model of tumor-immune interactions.

Mark Robertson-Tessi1, Ardith El-Kareh, Alain Goriely.   

Abstract

A mathematical model of the interactions between a growing tumor and the immune system is presented. The equations and parameters of the model are based on experimental and clinical results from published studies. The model includes the primary cell populations involved in effector T-cell mediated tumor killing: regulatory T cells, helper T cells, and dendritic cells. A key feature is the inclusion of multiple mechanisms of immunosuppression through the main cytokines and growth factors mediating the interactions between the cell populations. Decreased access of effector cells to the tumor interior with increasing tumor size is accounted for. The model is applied to tumors with different growth rates and antigenicities to gauge the relative importance of various immunosuppressive mechanisms. The most important factors leading to tumor escape are TGF-β-induced immunosuppression, conversion of helper T cells into regulatory T cells, and the limitation of immune cell access to the full tumor at large tumor sizes. The results suggest that for a given tumor growth rate, there is an optimal antigenicity maximizing the response of the immune system. Further increases in antigenicity result in increased immunosuppression, and therefore a decrease in tumor killing rate. This result may have implications for immunotherapies which modulate the effective antigenicity. Simulation of dendritic cell therapy with the model suggests that for some tumors, there is an optimal dose of transfused dendritic cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22051568     DOI: 10.1016/j.jtbi.2011.10.027

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  34 in total

1.  Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery.

Authors:  Juan Carlos López Alfonso; Jan Poleszczuk; Rachel Walker; Sungjune Kim; Shari Pilon-Thomas; Jose J Conejo-Garcia; Hatem Soliman; Brian Czerniecki; Louis B Harrison; Heiko Enderling
Journal:  JCO Clin Cancer Inform       Date:  2019-04

2.  A dynamic model of the immune response to the onset of a tumor.

Authors:  M Ya Antonovsky; M D Korzukhin
Journal:  Dokl Biochem Biophys       Date:  2013-08-23       Impact factor: 0.788

3.  Global Dynamics of a Breast Cancer Competition Model.

Authors:  Kristen Abernathy; Zachary Abernathy; Arden Baxter; Meghan Stevens
Journal:  Differ Equ Dyn Syst       Date:  2017-01-20

Review 4.  Mathematical modeling of tumor-immune cell interactions.

Authors:  Grace E Mahlbacher; Kara C Reihmer; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2019-03-02       Impact factor: 2.691

5.  Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions.

Authors:  H Hatzikirou; J C L Alfonso; S Mühle; C Stern; S Weiss; M Meyer-Hermann
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

6.  A tumor-immune mathematical model of CD4+ T helper cell dependent tumor regression by oncogene inactivation.

Authors:  Chinyere I Nwabugwu; Kavya Rakhra; Dean W Felsher; David S Paik
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

7.  Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy.

Authors:  Jason I Griffiths; Pierre Wallet; Lance T Pflieger; David Stenehjem; Xuan Liu; Patrick A Cosgrove; Neena A Leggett; Jasmine A McQuerry; Gajendra Shrestha; Maura Rossetti; Gemalene Sunga; Philip J Moos; Frederick R Adler; Jeffrey T Chang; Sunil Sharma; Andrea H Bild
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

Review 8.  Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.

Authors:  Anna Konstorum; Anthony T Vella; Adam J Adler; Reinhard C Laubenbacher
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

9.  An agent-based modeling framework linking inflammation and cancer using evolutionary principles: description of a generative hierarchy for the hallmarks of cancer and developing a bridge between mechanism and epidemiological data.

Authors:  Gary An; Swati Kulkarni
Journal:  Math Biosci       Date:  2014-08-01       Impact factor: 2.144

10.  In silico tumor control induced via alternating immunostimulating and immunosuppressive phases.

Authors:  A I Reppas; J C L Alfonso; H Hatzikirou
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.